FDA Names New Head of Drug Center Amid Leadership Change Following Ouster of George Tidmarsh

The Food and Drug Administration has appointed Rick Pazdur as the new leader of its drug center, replacing George Tidmarsh after he was ousted from his position as former drug director. Pazdur is a veteran regulator with extensive experience in overseeing cancer medicines at the agency. His appointment comes amid recent changes within the FDA's leadership structure. Pazdur will assume the role of director of the Office of New Drugs and Drugs Evaluation, one of the most senior positions at the agency.